Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$22.80 USD
+0.59 (2.66%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $22.80 0.00 (0.00%) 4:50 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC5/1/24 |
---|---|
Current Quarter | 0.18 |
EPS Last Quarter | 0.28 |
Last EPS Surprise | 12.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.92 |
Next Year | 1.33 |
EPS (TTM) | 0.95 |
P/E (F1) | 24.25 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 137.79M | 148.91M | 606.82M | 659.91M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 145.84M | 150.80M | 616.34M | 707.97M |
Low Estimate | 129.83M | 146.44M | 600.10M | 611.56M |
Year ago Sales | 105.65M | 117.72M | 482.38M | 606.82M |
Year over Year Growth Est. | 30.42% | 26.49% | 25.80% | 8.75% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.18 | 0.24 | 0.92 | 1.33 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | 0.19 | 0.20 | 0.84 | 1.14 |
High Estimate | 0.22 | 0.31 | 1.11 | 1.48 |
Low Estimate | 0.10 | 0.18 | 0.63 | 1.14 |
Year ago EPS | 0.14 | 0.25 | 0.94 | 0.92 |
Year over Year Growth Est. | 28.57% | -4.00% | -2.13% | 44.73% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.18 | 0.24 | 0.92 | 1.33 |
7 Days Ago | 0.18 | 0.24 | 0.92 | 1.33 |
30 Days Ago | 0.18 | 0.24 | 0.92 | 1.30 |
60 Days Ago | 0.17 | 0.21 | 0.87 | 1.25 |
90 Days Ago | 0.20 | 0.22 | 0.92 | 1.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.18 | 0.24 | 0.92 | 1.14 |
Zacks Consensus Estimate | 0.18 | 0.24 | 0.92 | 1.33 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -14.12% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.28 | 0.28 | 0.25 | 0.14 | NA |
Estimate | 0.25 | 0.22 | 0.15 | 0.20 | NA |
Difference | 0.03 | 0.06 | 0.10 | -0.06 | 0.03 |
Surprise | 12.00% | 27.27% | 66.67% | -30.00% | 18.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more